AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 2.540
-0.090 (-3.42%)
Jan 21, 2026, 4:35 PM CET
AcouSort AB Revenue
AcouSort AB had revenue of 2.11M SEK in the quarter ending September 30, 2025, with 12.13% growth. This brings the company's revenue in the last twelve months to 10.80M, up 34.53% year-over-year. In the year 2024, AcouSort AB had annual revenue of 10.03M, down -4.94%.
Revenue (ttm)
10.80M
Revenue Growth
+34.53%
P/S Ratio
5.15
Revenue / Employee
675.00K
Employees
16
Market Cap
55.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.03M | -521.00K | -4.94% |
| Dec 31, 2023 | 10.55M | 1.97M | 22.90% |
| Dec 31, 2022 | 8.59M | 2.63M | 44.07% |
| Dec 31, 2021 | 5.96M | -864.00K | -12.66% |
| Dec 31, 2020 | 6.82M | 3.78M | 124.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alzinova AB | 26.12M |
| Nanologica AB | 22.65M |
| Scandinavian ChemoTech AB | 11.68M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| Spago Nanomedical AB | 5.84M |
| OncoZenge AB | 2.78M |
| Simris Group AB (PUBL) | 2.30M |
| 2cureX AB | 1.98M |